成都先导：宁波聚智先导生物科技合伙企业（有限合伙）增持94.56万股（0.24%）股份

Core Viewpoint - Chengdu Xian Dao announced that its controlling shareholder, JINLI (Li Jin), and a concerted actor, Ningbo Juzhi Xian Dao Biotechnology Partnership (Limited Partnership), have completed a share buyback plan, acquiring a total of 945,600 A-shares, which represents 0.24% of the company's total share capital, for an amount of 25.0984 million yuan (excluding transaction fees) [1] Summary by Categories Share Buyback - The buyback period was from October 13, 2025, to January 30, 2026 [1] - A total of 945,600 shares were repurchased [1] - The total investment for the buyback was 25.0984 million yuan [1]